Open account
Sign up/Log in
BUZZ-U.S. STOCKS ON THE MOVE-Chemours, Lucid, OppFi
U.S. Stocks reverse early gains ahead of key inflation print. Dow Jones Industrial Average down 0.36%; S&P 500 and Nasdaq Composite also down. Chemours, Lucid, OppFi among the top stocks on the move. Lucid Group down 3.9% after announcing potential sale of parts of company.
Reuters · 04/09 18:19
BUZZ-U.S. STOCKS ON THE MOVE-Digital Realty, Alphabet, Moderna
Dow Jones Industrial Average was down 0.52% on Tuesday. Wall Street's main stock indexes gained on Tuesday supported by retreating Treasury yields. Investors await a key inflation print later in the week that could help shape the Fed's stance on interest-rate cuts. Digital Realty, Alphabet, Moderna are among the day's top stocks.
Reuters · 04/09 16:20
BUZZ-U.S. STOCKS ON THE MOVE-Bloom Energy, Hecla Mining, Alkermes
U.S. Stocks were poised for a higher open on Tuesday. Dow e-minis were up 0.05% ahead of a key inflation print later in the week. Top three NYSE percentage gainers premarket were Leju Holdings, Hecla Mining. Bloom Energy, American Eagle Outfitters, Alkermes among stocks on the move.
Reuters · 04/09 13:23
BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, Taysha Gene, American Eagle
U.S. Stock index futures were flat on Tuesday ahead of a crucial inflation reading later in the week. Gold miners, Taysha Gene, American Eagle and Bloom Energy are among the top stocks on the move. Dow e-minis were down 0.02% ahead of the open.
Reuters · 04/09 11:54
VINCERX PHARMA SHARES DOWN 53.1% PREMARKET AFTER CANCER THERAPY STUDY DATA COMES IN BELOW EXPECTATIONS
Reuters · 04/09 10:53
BUZZ-Vincerx Pharma tumbles as cancer therapy study data comes in below expectations
Shares of Vincerx Pharma slump 51.5% to $2.32 premarket after cancer therapy study data comes in below expectations. Company's experimental cancer therapy VIP236 demonstrated some anti-tumor activity, but was below investor expectations. Stock up three-fold YTD.
Reuters · 04/09 10:03
VINCERX PHARMA PRESENTS POSITIVE PRELIMINARY PHASE 1 DATA FOR VIP236 AND UPDATES ON PIPELINE PROGRESS AT THE AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) ANNUAL MEETING 2024
Reuters · 04/08 20:30
Vincerx Pharma Inc reports results for the quarter ended in December - Earnings Summary
Vincerx Pharma Inc reports results for the quarter ended in December. The company reported a quarterly adjusted loss of 23 cents per share. The mean expectation of three analysts was for a loss of 37 cents. Reported revenue was zero; analysts expected zero. Shares had risen by 413.6% this quarter.
Reuters · 03/29 21:03
Webull offers Vincerx Pharma Inc stock information, including NASDAQ: VINCU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VINCU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading VINCU stock methods without spending real money on the virtual paper trading platform.